SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 129.14 |
| Enterprise Value ($M) | 109.67 |
| Book Value ($M) | 58.92 |
| Book Value / Share | 0.26 |
| Price / Book | 2.19 |
| NCAV ($M) | -39.20 |
| NCAV / Share | -0.17 |
| Price / NCAV | -3.29 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.81 |
| Return on Assets (ROA) | -0.73 |
| Return on Equity (ROE) | -1.16 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.75 |
| Current Ratio | 0.75 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 68.26 |
| Assets | 166.39 |
| Liabilities | 107.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 28.70 |
| Operating Income | -66.29 |
| Net Income | -66.95 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -44.76 |
| Cash from Investing | -21.32 |
| Cash from Financing | 56.56 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Sio Capital Management, LLC | 5.06 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 750,989 | 2,194,780 | 34.22 | |
| 531,346 | 1,908,193 | 27.85 | |
| 357,484 | 883,424 | 40.47 | |
| 524,396 | 1,287,917 | 40.72 | |
| 392,914 | 1,255,267 | 31.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VSTM – Verastem, Inc. | VTGN – Vistagen Therapeutics, Inc. |
| VTVT – vTv Therapeutics Inc. | VYNE – VYNE Therapeutics Inc. |
| WHWK – Whitehawk Therapeutics, Inc. |